Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic calcipotriol-betamethasone ointment versus Daivobet and vehicle in adult plaque psoriasis
2013-002861-20Phase 3Completed
- Sponsor
- Lek
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcipotriol + betamethasone in plaque psoriasis (3 arms), sponsored by Lek. Primary endpoint: Mean percent change from baseline in modified PASI score at end of treatment. Started Oct 2013; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2013-002861-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002861-20.